Brand Performance logo
to receive information about changes in the popularity of this brand.

Moilec ranks 26th of 27 brands in the Painkillers and anti-inflammatory drugs category with a 0.04% share over the last four weeks.

The category leader is Ibuprom with a 31.24% share.

Its monthly share for October 2026 was 0.03%, compared with 0.02% the month before.

Its highest monthly share in the period shown, 0.11%, came in April 2025.

Data comes from the shopping lists of Listonic and Moja Gazetka app users and is updated weekly.

BRAND CHARTS
Udział procentowy marek w kategorii Painkillers and anti-inflammatory drugs
MarkaUdział procentowy
Ibuprom31.24%
Ibuprofen13.36%
Apap12.11%
Paracetamol11.67%
Ibum6.95%
Nurofen6.19%
Pyralgina3.88%
Polopiryna2.78%
Voltaren2.71%
Ketonal2.04%
Ibufen1.35%
Opokan0.94%
Metafen0.67%
Aspirin0.66%
Naproxen0.62%
Etopiryna0.52%
Olfen0.52%
Excedrin0.36%
Nomigren0.33%
Efferalgan0.31%
Panadol0.26%
Traumon0.17%
Kidofen Duo0.11%
Aleve0.11%
Reparil0.08%
Moilec0.04%
Kopiryna0.01%

Brand Moilec percentage share in the category Painkillers and anti-inflammatory drugs in the last month

The chart shows data for the 4 weeks leading up to the selected date. The information is updated every Monday and includes data up to Sunday.
0.04%Moilec
ALL BRANDS
Historical market share of brands in the Painkillers and anti-inflammatory drugs category (monthly)
MonthParacetamolPyralginaIbupromPolopirynaNurofenMetafenPanadolIbufenApapIbumAspirinIbuprofenEtopirynaAleveEfferalganExcedrinKetonalKidofen DuoKopirynaNaproxenOlfenOpokanNomigrenVoltarenMoilecTraumonReparil
November 202410.80%3.71%31.29%3.30%8.24%1.27%0.41%1.50%11.58%7.45%0.79%10.24%0.30%0.17%0.47%0.48%2.56%0.27%0.03%0.64%0.50%0.82%0.08%2.53%0.06%0.44%0.06%
December 202411.20%3.48%30.16%3.25%8.97%0.68%0.34%1.61%12.30%7.68%0.85%11.58%0.51%0.15%0.31%0.36%1.83%0.13%0.01%0.58%0.42%1.11%0.19%1.91%0.06%0.22%0.12%
January 202512.40%3.55%27.94%3.58%8.34%0.68%0.28%1.65%12.32%8.33%0.95%10.92%0.43%0.25%0.36%0.29%2.08%0.28%0.02%0.81%0.52%0.98%0.16%2.16%0.06%0.53%0.13%
February 202511.30%3.45%28.97%3.55%8.85%0.83%0.48%1.81%11.93%7.79%0.82%11.36%0.44%0.16%0.46%0.31%2.48%0.21%0.01%0.57%0.46%0.68%0.18%2.33%0.05%0.42%0.12%
March 202511.17%3.18%29.94%2.88%8.40%0.82%0.35%1.65%12.31%7.13%0.67%12.41%0.52%0.29%0.27%0.26%2.52%0.13%0.00%0.80%0.46%0.77%0.22%2.23%0.06%0.48%0.09%
April 202510.97%3.58%30.96%2.52%7.21%0.76%0.35%1.57%12.38%7.38%0.55%11.64%0.44%0.09%0.21%0.49%2.68%0.15%0.03%0.95%0.58%1.02%0.26%2.58%0.11%0.41%0.12%
May 202511.17%3.42%30.07%2.02%7.34%0.78%0.41%1.08%12.46%7.34%0.45%12.13%0.48%0.40%0.29%0.46%2.75%0.24%0.03%0.57%0.57%1.37%0.13%3.42%0.05%0.46%0.13%
June 202512.04%3.22%31.14%1.34%7.99%0.71%0.38%1.53%12.47%7.57%0.29%11.35%0.45%0.27%0.35%0.38%2.36%0.08%0.05%0.82%0.42%0.98%0.21%2.83%0.06%0.48%0.24%
July 202510.37%3.22%32.07%1.15%8.08%0.79%0.48%1.34%12.65%7.82%0.26%11.81%0.60%0.23%0.32%0.33%2.55%0.12%0.03%0.74%0.61%1.05%0.13%2.58%0.07%0.51%0.10%
August 202510.89%3.48%30.55%1.43%7.73%0.71%0.33%1.40%13.32%6.81%0.59%11.62%0.69%0.27%0.22%0.32%3.01%0.10%0.03%0.81%0.68%1.21%0.23%2.86%0.06%0.48%0.16%
September 202512.31%3.30%29.97%2.57%7.28%0.73%0.37%1.34%11.97%6.87%0.73%12.79%0.24%0.49%0.34%0.40%2.79%0.15%0.03%0.79%0.34%1.11%0.21%2.42%0.02%0.35%0.09%
October 202511.51%3.58%31.02%3.77%7.54%0.87%0.46%0.91%11.70%6.44%0.79%12.02%0.35%0.29%0.51%0.24%2.24%0.06%0.00%1.08%0.59%0.94%0.16%2.46%0.06%0.38%0.03%
November 202510.37%3.34%30.24%3.12%7.92%0.97%0.22%1.25%12.48%6.63%0.68%12.49%0.36%0.37%0.44%0.20%2.80%0.05%0.05%0.73%0.70%1.24%0.22%2.61%0.03%0.36%0.14%
December 202511.48%3.51%30.77%2.91%8.84%0.79%0.23%1.49%11.43%8.13%0.72%11.45%0.49%0.14%0.48%0.27%2.12%0.15%0.01%0.75%0.54%0.73%0.28%1.91%0.04%0.23%0.07%
January 202613.17%4.11%28.82%2.67%8.06%0.69%0.32%1.20%11.68%6.96%0.70%12.82%0.36%0.06%0.30%0.32%2.05%0.10%0.02%0.70%0.52%0.92%0.14%2.60%0.05%0.46%0.20%
February 202612.58%3.58%28.81%3.32%8.19%0.84%0.41%1.92%11.80%7.03%0.66%12.01%0.38%0.03%0.34%0.49%1.99%0.21%0.01%0.77%0.55%0.94%0.22%2.55%0.00%0.29%0.10%
March 202612.53%3.57%30.19%2.38%6.99%0.82%0.45%1.30%11.90%6.78%0.66%12.34%0.40%0.12%0.24%0.45%2.72%0.16%0.05%0.64%0.43%1.39%0.23%2.69%0.00%0.49%0.07%
April 202611.38%3.78%30.16%2.65%7.36%0.92%0.32%1.48%12.22%6.78%0.48%12.57%0.60%0.08%0.24%0.39%2.10%0.19%0.00%0.81%0.60%1.10%0.26%2.94%0.05%0.40%0.16%
May 202611.57%3.83%30.34%1.73%7.30%0.59%0.44%1.32%12.46%6.48%0.41%13.04%0.50%0.04%0.25%0.34%2.83%0.09%0.02%0.93%0.68%1.28%0.18%2.92%0.04%0.36%0.09%
June 202612.44%3.19%31.79%1.19%7.28%0.69%0.23%1.45%12.35%6.99%0.41%13.01%0.48%0.06%0.29%0.30%2.41%0.14%0.00%0.77%0.48%1.07%0.22%2.40%0.05%0.26%0.06%
July 202612.00%3.54%30.20%1.01%7.96%0.63%0.38%1.34%12.36%7.33%0.41%12.37%0.33%0.11%0.35%0.35%2.63%0.11%0.02%0.81%0.43%1.53%0.30%2.81%0.07%0.49%0.13%
August 202612.01%3.91%29.56%1.31%7.04%0.75%0.23%1.15%12.89%7.56%0.31%12.65%0.66%0.15%0.21%0.29%2.53%0.04%0.03%0.82%0.56%1.30%0.49%3.03%0.01%0.46%0.06%
September 202612.21%3.68%31.36%2.21%6.34%0.74%0.33%1.17%12.21%6.54%0.50%13.51%0.42%0.06%0.33%0.30%2.50%0.11%0.00%0.61%0.37%0.99%0.28%2.83%0.02%0.26%0.13%
October 202611.59%3.81%30.97%2.68%6.49%0.62%0.28%1.39%12.22%6.79%0.72%13.21%0.53%0.07%0.22%0.30%2.09%0.10%0.01%0.67%0.58%0.98%0.30%3.07%0.03%0.21%0.08%

Percentage share of tagged brands in individual months

How the share of the selected brands in the Painkillers and anti-inflammatory drugs category has changed over the months
The method of counting additions changed in June 2026 – comparisons with periods before that date may not be fully reliable.
Show data up to:
Range:
SUBCATEGORY CHARTS

Time to store

Shows how much time passes from adding a product from a given subcategory to a shopping list to the moment of purchase
637.7 h(27 days)
Painkillers and anti-inflammatory drugs
Type Planned | Over 72 h
Products added well in advance and purchased during planned, less frequent shopping trips. The long time from list to purchase reflects a deliberate, cyclical decision.
Comparison with the other subcategories in “Health”
Fertility drugs
Condoms
Heartburn medicines
Dietary supplements and vitamins for children
Dietary supplements and vitamins for adults
Protein supplements
Cold and runny nose medicines
Digestive medicines
0 h
47.9 h (2 days)
54.3 h (2 days)
62.3 h (3 days)
63.4 h (3 days)
178.1 h (7 days)
197.9 h (8 days)
408.2 h (17 days)
Median of the Health category: 408.2 h (17 days)
Allergy medicines
Contact lenses
Antispasmodics
Painkillers and anti-inflammatory drugs
Medicines for herpes and skin problems
Potency and libido medicines
449.5 h (19 days)
541.1 h (23 days)
544.7 h (23 days)
637.7 h (27 days)
824.1 h (34 days)
3,324.3 h (139 days)
Real Purchase Rate – Annual data for the Painkillers and anti-inflammatory drugs subcategory compared with the other subcategories in Health.
SubcategoryRPR (%)
Medicines for herpes and skin problems82%
Contact lenses82%
Condoms81%
Cold and runny nose medicines81%
Digestive medicines81%
Allergy medicines80%
Heartburn medicines80%
Protein supplements80%
Painkillers and anti-inflammatory drugs80%
Dietary supplements and vitamins for adults77%
Antispasmodics76%
Fertility drugs76%
Potency and libido medicines75%
Dietary supplements and vitamins for children70%

Real Purchase Rate (RPR)

Shows what percentage of products added to shopping lists were actually purchased. Annual data for the Painkillers and anti-inflammatory drugs subcategory compared with the other subcategories in Health.
Brand Loyalty Index (BLI) marki w kategorii Painkillers and anti-inflammatory drugs (miesięcznie)
MiesiącBLI (%)
2024-11-01T00:00:0084.63%
2024-12-01T00:00:0084.93%
2025-01-01T00:00:0087.33%
2025-02-01T00:00:0086.70%
2025-03-01T00:00:0083.54%
2025-04-01T00:00:0084.52%
2025-05-01T00:00:0082.11%
2025-06-01T00:00:0082.58%
2025-07-01T00:00:0080.67%
2025-08-01T00:00:0081.59%
2025-09-01T00:00:0080.29%
2025-10-01T00:00:0084.19%
2025-11-01T00:00:0086.83%
2025-12-01T00:00:0094.64%
2026-01-01T00:00:0086.00%
2026-02-01T00:00:0083.58%
2026-03-01T00:00:0082.64%
2026-04-01T00:00:0081.70%
2026-05-01T00:00:0081.46%
2026-06-01T00:00:0081.17%
2026-07-01T00:00:0081.13%
2026-08-01T00:00:0081.82%
2026-09-01T00:00:0082.84%
2026-10-01T00:00:0064.46%
-20.10%

BLI - Brand Loyalty Index

The Brand Loyalty Index (BLI) indicates the degree of Listonic app users attachment to individual brands. It shows what percentage of products in category Painkillers and anti-inflammatory drugs added to the Listonic shopping list are entered with the brand.
Show data up to:
Range:
Bezwzględna liczba dodań produktów z kategorii Painkillers and anti-inflammatory drugs (miesięcznie)
MiesiącDodania z markąWszystkie dodania z kategorii
2024-11-01T00:00:0066007799
2024-12-01T00:00:00858410107
2025-01-01T00:00:0086549910
2025-02-01T00:00:0076928872
2025-03-01T00:00:0069138275
2025-04-01T00:00:0065577758
2025-05-01T00:00:0062927663
2025-06-01T00:00:0066188014
2025-07-01T00:00:0068698515
2025-08-01T00:00:0069178478
2025-09-01T00:00:0065668178
2025-10-01T00:00:0062907471
2025-11-01T00:00:0058996794
2025-12-01T00:00:0080988557
2026-01-01T00:00:0084009767
2026-02-01T00:00:0071448548
2026-03-01T00:00:0057636974
2026-04-01T00:00:0061977585
2026-05-01T00:00:0056206899
2026-06-01T00:00:001036112765
2026-07-01T00:00:001648520320
2026-08-01T00:00:001582619342
2026-09-01T00:00:001590719201
2026-10-01T00:00:001506223368

Additions of a product from category Painkillers and anti-inflammatory drugs

Absolute data on adding products from category Painkillers and anti-inflammatory drugs with a brand compared to all additions from the category.
The method of counting additions changed in June 2026 – comparisons with periods before that date may not be fully reliable.
Show data up to:
Range:
Number of additions Painkillers and anti-inflammatory drugs
Number of additions Painkillers and anti-inflammatory drugs with the brand
The data for the analysis comes from shopping lists in Listonic and Moja Gazetka. The study has been supplemented with data from Moja Gazetka since October 2024.From June 2026 the method of counting additions has been refined: re-marking a product as to buy after it was previously checked off as bought (an "uncheck") now also counts as an addition to the list. This change affects data from June 2026 onwards – worth bearing in mind when comparing with earlier periods.
Is your brand missing from the comparison?
Want to increase your sales?Contact us